Loading provider…
Loading provider…
Pediatrics Physician in Gonzales, TX
NPI: 1306800941Primary Practice Location
Community Health Centers of South Central Texas, Inc.
228 St George St, Gonzales, TX
Primary Employer
Community Health Centers of South Central Texas, Inc.
communityhealthtx.com
HQ Phone
Get MD Larry's Phone Numberphone_androidMobile
Get MD Larry's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
PA State Medical License
TX State Medical License
TX State Medical License
1992 - 2027
AZ State Medical License
2011 - 2015
NJ State Medical License
2008 - 2013
PA State Medical License
2005 - 2008

American Board of Pediatrics
Pediatrics
University of Texas Southwestern Medical Center
Fellowship • Pediatric Hematology/Oncology
1994 - 1999
Texas A&M College of Medicine - Bryan
medicine.tamu.edu
Medical School
Until 1991
Baylor Scott & White Medical Center - Baylor College of Medicine (Temple)
Residency • Pediatrics
1991 - 1994
BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.
Authors: Stoklosa, Tomasz, Poplawski, Tomasz, Koptyra, Mateusz, Nieborowska-Skorska, Margaret, Basak, Grzegorz, Slupianek, Artur, Rayevskaya, Marina, Seferynska, Ilona, Herrera, Larry, Blasiak, Janusz, Skorski, Tomasz
Journal: Cancer Res
Authors: Herrera, L, Stanciu-Herrera, C, Morgan, C, Ghetie, V, Vitetta, E S
Journal: Leuk Lymphoma
Authors: Stanciu-Herrera, C, Morgan, C, Herrera, L
Journal: Leuk Res
Publication Date: 2007-08-15
Lead Sponsor: Albert Einstein College of Medicine
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Cytarabine, BIOLOGICAL: Deglycosylated Ricin A Chain-Conjugated Anti-CD19/Anti-CD22 Immunotoxins
Lead Sponsor: Albert Einstein College of Medicine
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins